AKOYA BIOSCIENCES INC (AKYA)

US00974H1041 - Common Stock

2.41  -0.08 (-3.21%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
54.92M
29.41%
74.86M
36.31%
96.633M
29.08%
83.606M
-13.48%
93.434M
11.76%
107.71M
15.28%
113.12M
5.02%
122.91M
8.65%
165.95M
35.02%
185.84M
11.99%
206.24M
10.98%
EBITDA
YoY % growth
-34.51M
-321.37%
-58.96M
-70.85%
-48.778M
17.27%
-33.978M
30.34%
-12.987M
61.78%
-501.024K
96.14%
-6.018M
-1,101.14%
4.794M
179.66%
16.932M
253.19%
N/AN/A
EBIT
YoY % growth
-39.3M
-227.23%
-66.11M
-68.22%
-57.668M
12.77%
-43.908M
23.86%
-24.894M
43.30%
-17.743M
28.73%
-22.491M
-26.76%
-17.748M
21.09%
5.61M
131.61%
17.034M
203.64%
29.07M
70.66%
Operating Margin
-71.56%-88.31%-59.68%-52.52%-26.64%-16.47%-19.88%-14.44%3.38%9.17%14.10%
EPS
YoY % growth
-4.52-1.88
58.41%
-1.43
23.94%
-1.12
21.90%
-0.63
43.26%
-0.45
28.48%
-0.47
-3.54%
-0.38
19.57%
-0.10
72.97%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.15
30.45%
-0.21
56.89%
-0.17
37.40%
-0.15
27.14%
-0.13
15.24%
-0.20
3.87%
-0.13
21.55%
-0.09
40.00%
-0.08
37.08%
Revenue
Q2Q % growth
23.36M
-11.81%
20.745M
13.05%
23.828M
2.87%
25.255M
34.24%
28.632M
22.57%
22.593M
8.91%
26.979M
13.22%
27.948M
10.66%
30.498M
6.52%
EBITDA
Q2Q % growth
-2.555M
-365.45%
-4.035M
73.40%
-3.045M
57.15%
-2.056M
-139.90%
1.298M
150.80%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-5.452M
42.24%
-7.861M
54.34%
-6.253M
43.58%
-5.209M
21.77%
-3.663M
32.81%
-7.344M
6.57%
-3.978M
36.39%
-2.754M
47.13%
-2.448M
33.17%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.21
19.23%
-0.210.00-1.05%
Q2 2024
Q2Q % growth
-0.27
41.30%
-0.270.001.15%
Q1 2024
Q2Q % growth
-0.48
2.04%
-0.29-0.19-62.97%
Q4 2023
Q2Q % growth
-0.22
56.00%
-0.270.0519.69%
Q3 2023
Q2Q % growth
-0.26
44.68%
-0.370.1130.30%
Q2 2023
Q2Q % growth
-0.46
2.13%
-0.45-0.01-1.83%
Q1 2023
Q2Q % growth
-0.49
-11.36%
-0.490.000.51%
Q4 2022
Q2Q % growth
-0.50
-6.38%
-0.44-0.06-14.00%
Q3 2022
Q2Q % growth
-0.47
-51.61%
-0.45-0.02-4.72%
Q2 2022
Q2Q % growth
-0.47
-135.00%
-0.38-0.09-23.87%
Q1 2022
Q2Q % growth
-0.44
87.57%
-0.40-0.04-11.32%
Q4 2021
Q2Q % growth
-0.47 -0.32-0.15-48.64%
Q3 2021
Q2Q % growth
-0.31 -0.27-0.04-14.69%
Q2 2021
Q2Q % growth
-0.20 -0.230.0314.75%
Q1 2021
Q2Q % growth
-3.54 -0.17-3.37-1,971.99%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
18.814M
-25.12%
25.929M-7.115M-27.44%
Q2 2024
Q2Q % growth
23.164M
-1.52%
24.023M-859K-3.58%
Q1 2024
Q2Q % growth
18.35M
-14.29%
24.767M-6.417M-25.91%
Q4 2023
Q2Q % growth
26.487M
24.82%
26.408M79K0.30%
Q3 2023
Q2Q % growth
25.125M
33.29%
25.031M94K0.38%
Q2 2023
Q2Q % growth
23.521M
31.48%
22.887M634K2.77%
Q1 2023
Q2Q % growth
21.41M
26.76%
20.727M683K3.30%
Q4 2022
Q2Q % growth
21.22M
31.31%
20.994M226K1.08%
Q3 2022
Q2Q % growth
18.85M
39.84%
18.011M839K4.66%
Q2 2022
Q2Q % growth
17.89M
36.88%
17.238M652K3.78%
Q1 2022
Q2Q % growth
16.89M
38.33%
15.232M1.658M10.88%
Q4 2021
Q2Q % growth
16.16M
25.17%
16.371M-211K-1.29%
Q3 2021
Q2Q % growth
13.48M
35.48%
13.243M237K1.79%
Q2 2021
Q2Q % growth
13.07M
52.69%
12.818M252K1.97%
Q1 2021
Q2Q % growth
12.21M
10.80%
12.269M-59K-0.48%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.45% -10.09% -7.09% -7.09%
Revenue-4.29% -30% -16.54% -16.37%